GIP and hydrops fetalis: An alternative pharmacological treatment is tirzepatide, a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, demonstrating greater weight loss effectiveness compared to semaglutide in HF.